APPLICATION
ANDA207611
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-05
LATEST ACTION
2026-03-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
VALPROIC ACIDDiscontinued
VALPROIC ACID 250MG · CAPSULE · ORAL
Approval history
2026-03-31Labeling · Supplement 3 · standardAP
2022-07-06Labeling · Supplement 1 · standardAP
2019-08-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.